The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Cancer stem cells (CSCs) in cancer progression and therapy
Abstract
Cancer stem cells (CSCs) are self‐renewable cell types that are identified in most types of liquid and solid cancers and contributed to tumor onset, expansion, resistance, recurrence, and metastasis after therapy. CSCs are identified from the expression of cell surface markers, which is tumor‐type dependent. The transition between CSCs with cancer cells and other non‐CSCs occurs in cancers, which is possibly under the control of signals from CSCs and tumor microenvironment (TME), including CSC niche. Cancer‐associated fibroblasts are among the most influential cells for promoting both differentiation of CSCs and dedifferentiation of non‐CSCs toward attaining a CSC‐like phenotype. WNT/β‐catenin, transforming growth factor‐β, Hedgehog, and Notch are important signals for maintaining self‐renewal in CSCs. An effective therapeutic strategy relies on targeting both CSCs and non‐CSCs to remove a possible chance of tumor relapse. There are multiple ways to target CSCs, including immunotherapy, hormone therapy, (mi)siRNA delivery, and gene knockout. Such approaches can be designed for suppressing CSC stemness, tumorigenic cues from TME, CSC extrinsic and/or intrinsic signaling, hypoxia or for promoting differentiation in the cells. Because of sharing a range of characteristics to normal stem/progenitor cells, CSCs must be targeted based on their unique markers and their preferential expression of antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102454108 · Cited by 1,147
Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., & Boman, B. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4418 · Cited by 1,045
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
Vescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905
Chaffer, C. L., Marjanovic, N. D., Lee, T., Bell, G., Kleer, C. G., Reinhardt, F., D’Alessio, A. C., Young, R. A., & Weinberg, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.06.005 · Cited by 876
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Visualization and targeting of LGR5+ human colon cancer stem cells
Shimokawa, M., Ohta, Y., Nishikori, S., Matano, M., Takano, A., Fujii, M., Date, S., Sugimoto, S., Kanai, T., & Sato, T. (2017) · Nature · doi:10.1038/nature22081 · Cited by 728
Making a tumour's bed: glioblastoma stem cells and the vascular niche
Gilbertson, R. J., & Rich, J. N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2246 · Cited by 715
Stem cell fate in cancer growth, progression and therapy resistance
Lytle, N. K., Barber, A. G., & Reya, T. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0056-x · Cited by 647
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Malanchi, I., Peinado, H., Kassen, D., Hussenet, T., Metzger, D., Chambon, P., Huber, M., Hohl, D., Cano, A., Birchmeier, W., et al. (2008) · Nature · doi:10.1038/nature06835 · Cited by 597
Macrophage polarity in cancer: A review
Najafi, M., Hashemi Goradel, N., Farhood, B., Salehi, E., Nashtaei, M. S., Khanlarkhani, N., Khezri, Z., Majidpoor, J., Abouzaripour, M., Habibi, M., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27646 · Cited by 489
Self-citationMicroenvironmental regulation of stem cells in intestinal homeostasis and cancer
Medema, J. P., & Vermeulen, L. (2011) · Nature · doi:10.1038/nature10212 · Cited by 472
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
Comoglio, P. M., Trusolino, L., & Boccaccio, C. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0002-y · Cited by 381
Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.407 · Cited by 377
Kato, T., Noma, K., Ohara, T., Kashima, H., Katsura, Y., Sato, H., Komoto, S., Katsube, R., Ninomiya, T., Tazawa, H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0205 · Cited by 367
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
Lasorella, A., Benezra, R., & Iavarone, A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3638 · Cited by 355
Cancer stem cell in breast cancer therapeutic resistance
Bai, X., Ni, J., Beretov, J., Graham, P., & Li, Y. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.004 · Cited by 328
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
Wang, D., Fu, L., Sun, H., Guo, L., & DuBois, R. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.064 · Cited by 292
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Du, X., Tang, F., Liu, M., Su, J., Zhang, Y., Wu, W., Devenport, M., Lazarski, C. A., Zhang, P., Wang, X., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0011-0 · Cited by 249
Emerging role of lipid metabolism alterations in Cancer stem cells
Yi, M., Li, J., Chen, S., Cai, J., Ban, Y., Peng, Q., Zhou, Y., Zeng, Z., Peng, S., Li, X., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0784-5 · Cited by 248
Liu, C., Liu, R., Zhang, D., Deng, Q., Liu, B., Chao, H.-P., Rycaj, K., Takata, Y., Lin, K., Lu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14270 · Cited by 228
Wu, C. X., Wang, X. Q., Chok, S. H., Man, K., Tsang, S. H. Y., Chan, A. C. Y., Ma, K. W., Xia, W., & Cheung, T. T. (2018) · Theranostics · doi:10.7150/thno.25487 · Cited by 228
Cancer cell plasticity: Impact on tumor progression and therapy response
da Silva-Diz, V., Lorenzo-Sanz, L., Bernat-Peguera, A., Lopez-Cerda, M., & Muñoz, P. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.009 · Cited by 203
Xiang, T., Long, H., He, L., Han, X., Lin, K., Liang, Z., Zhuo, W., Xie, R., & Zhu, B. (2015) · Oncogene · doi:10.1038/onc.2013.537 · Cited by 194
Carruthers, R. D., Ahmed, S. U., Ramachandran, S., Strathdee, K., Kurian, K. M., Hedley, A., Gomez-Roman, N., Kalna, G., Neilson, M., Gilmour, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0569 · Cited by 176
Siriwon, N., Kim, Y. J., Siegler, E., Chen, X., Rohrs, J. A., Liu, Y., & Wang, P. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0502 · Cited by 169
A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells
El Hout, M., Dos Santos, L., Hamaï, A., & Mehrpour, M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.009 · Cited by 168
Lenos, K. J., Miedema, D. M., Lodestijn, S. C., Nijman, L. E., van den Bosch, T., Romero Ros, X., Lourenço, F. C., Lecca, M. C., van der Heijden, M., van Neerven, S. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0179-z · Cited by 168
ISG15 Is a Critical Microenvironmental Factor for Pancreatic Cancer Stem Cells
Sainz, B., Martín, B., Tatari, M., Heeschen, C., & Guerra, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1354 · Cited by 166
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Shi, Y., Guryanova, O. A., Zhou, W., Liu, C., Huang, Z., Fang, X., Wang, X., Chen, C., Wu, Q., He, Z., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6816 · Cited by 152
Sáinz, B., Alcalá, S., García, E., Sanchez-Ripoll, Y., Azevedo, M. M., Cioffi, M., Tatari, M. N., Miranda‐Lorenzo, I., Hidalgo, M. M., Goméz-López, G., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308935 · Cited by 146
Zappasodi, R., Budhu, S., Hellmann, M. D., Postow, M. A., Senbabaoglu, Y., Manne, S., Gasmi, B., Liu, C., Zhong, H., Li, Y., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.009 · Cited by 142
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140
Cancer stem cells: Regulation programs, immunological properties and immunotherapy
Zhang, D., Tang, D. G., & Rycaj, K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.001 · Cited by 137
Lan, J., Lu, H., Samanta, D., Salman, S., Lü, Y., & Semenza, G. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809695115 · Cited by 134
Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
Baquero, P., Dawson, A., Mukhopadhyay, A., Kuntz, E. M., Mitchell, R., Olivares, O., Ianniciello, A., Scott, M. T., Dunn, K. M., Nicastri, M. C., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0252-4 · Cited by 133
MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells
Talukdar, S., Pradhan, A. K., Bhoopathi, P., Shen, X., August, L. A., Windle, J. J., Sarkar, D., Furnari, F. B., Cavenee, W. K., Das, S. K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721650115 · Cited by 131
Goto, H., Shimono, Y., Funakoshi, Y., Imamura, Y., Toyoda, M., Kiyota, N., Kono, S., Takao, S., Mukohara, T., & Minami, H. (2018) · Oncogene · doi:10.1038/s41388-018-0477-8 · Cited by 130
Zuo, Z.-Q., Chen, K., Yu, X., Zhao, G., Shen, S., Cao, Z., Luo, Y., Wang, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.014 · Cited by 127
Nakano, M., Kikushige, Y., Miyawaki, K., Kunisaki, Y., Mizuno, S., Takenaka, K., Tamura, S., Okumura, Y., Ito, M., Ariyama, H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0480-0 · Cited by 125
IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor
Chen, L., Wang, S., Wang, Y., Zhang, W., Ma, K., Hu, C., Zhu, H., Liang, S., Liu, M., & Xu, N. (2018) · Oncotarget · doi:10.18632/oncotarget.24734 · Cited by 118
Cancer‐associated fibroblasts: Secretions, interactions, and therapy
Farhood, B., Najafi, M., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27703 · Cited by 114
Self-citationQin, X., Suzuki, H., Honda, M., Okada, H., Kaneko, S., Inoue, I., Ebisui, E., Hashimoto, K., Carninci, P., Kanki, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802279115 · Cited by 112
Baker, A. T., Wyatt, D. L., Bocchetta, M., Li, J., Filipović, A., Green, A. R., Peiffer, D. S., Fuqua, S. A. W., Miele, L., Albain, K. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0251-y · Cited by 108
Lee, J. H., Yun, C. W., Han, Y., Kim, S., Jeong, D., Kwon, H. Y., Kim, H., Baek, M. J., & Lee, S. H. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12519 · Cited by 107
Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells
Garcia, V. A., González, A., Alonso‐González, C., Martínez‐Campa, C., & Cos, S. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12007 · Cited by 106
Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1
Nimmakayala, R. K., Seshacharyulu, P., Lakshmanan, I., Rachagani, S., Chugh, S., Karmakar, S., Rauth, S., Vengoji, R., Atri, P., Talmon, G. A., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.041 · Cited by 106
Pancreatic cancer stem cells: A state or an entity?
Hermann, P. C., & Sáinz, B. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.007 · Cited by 103
Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
Zakaria, N., Yusoff, N. M., Zakaria, Z., Widera, D., & Yahaya, B. H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00166 · Cited by 102
Melatonin application in targeting oxidative‐induced liver injuries: A review
Mortezaee, K., & Khanlarkhani, N. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26209 · Cited by 101
Self-citationFOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC
Cao, S., Wang, Z., Gao, X., He, W., Cai, Y., Chen, H., & Xu, R. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0894-0 · Cited by 100
Lu, H., Tran, T. M. L., Park, Y., Chen, I., Lan, J., Xie, Y., & Semenza, G. L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0270 · Cited by 99
Liu, Z., Zhang, W., Phillips, J. B., Arora, R., McClellan, S. B., Li, J., Kim, J. H., Sobol, R. W., & Tan, M. (2018) · Oncogene · doi:10.1038/s41388-018-0407-9 · Cited by 96
Marquardt, S., Solanki, M., Spitschak, A., Vera, J., & Pützer, B. M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.006 · Cited by 92
Jin, Y., Wang, M., Hu, H., Huang, Q., Chen, Y., & Wang, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.151 · Cited by 91
Adjuvant chemotherapy with melatonin for targeting human cancers: A review
Najafi, M., Salehi, E., Farhood, B., Nashtaei, M. S., Goradel, N. H., Khanlarkhani, N., Namjoo, Z., & Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27259 · Cited by 83
Self-citationAnti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice
Ghalamfarsa, G., Rastegari, A., Atyabi, F., Hassannia, H., Hojjat‐Farsangi, M., Ghanbari, A., Anvari, E., Mohammadi, J., Azizi, G., Masjedi, A., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26743 · Cited by 82
Huang, H., Wang, C., Liu, F., Li, H., Peng, G., Gao, X., Dong, K., Wang, H., Kong, D.-P., Qu, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0461 · Cited by 74
Gao, X., Sheng, Y., Yang, J. L., Wang, C., Zhang, R., Zhu, Y., Zhang, Z., Zhang, K., Yan, S., Sun, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0832-1 · Cited by 74
Inhibition of cancer stem cell like cells by a synthetic retinoid
Chen, J., Cao, X., An, Q., Zhang, Y., Li, K., Yao, W., Shi, F., Pan, Y., Jia, Q., Zhou, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03877-7 · Cited by 72
Human hepatocellular carcinoma: Protection by melatonin
Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26586 · Cited by 72
Self-citationOoki, A., Dinalankara, W., Marchionni, L., Tsay, J.-C. J., Goparaju, C. M. V., Maleki, Z., Rom, W. N., Pass, H. I., & Hoque, M. O. (2018) · Oncogene · doi:10.1038/s41388-018-0373-2 · Cited by 72
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
Her, N.-G., Oh, J.-W., Oh, Y. J., Han, S., Cho, H. J., Lee, Y., Ryu, G. H., & Nam, D.-H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0825-1 · Cited by 68
Cysteine cathepsins: Their biological and molecular significance in cancer stem cells
Pišlar, A. H., Jewett, A., & Kos, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.010 · Cited by 67
Chen, X., Wu, L., Li, D., Xu, Y., Zhang, L., Niu, K., Kong, R., Gu, J., Xu, Z., Chen, Z., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1527 · Cited by 66
Matsunaga, N., Ogino, T., Hara, Y., Tanaka, T., Koyanagi, S., & Ohdo, S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-4034 · Cited by 64
Han, K., Lang, T., Zhang, Z., Zhang, Y., Sun, Y., Shen, Z., Beuerman, R. W., Zhou, L., & Min, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-26761-2 · Cited by 64
Targeting the Colorectal Cancer Stem Cell
Medema, J. P. (2017) · New England Journal of Medicine · doi:10.1056/nejmcibr1706541 · Cited by 63
Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
Li, L., Li, J.-C., Yang, H., Zhang, X., Liu, L., Li, Y., Zeng, T., Zhu, Y.-H., Li, X.-D., Li, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806219115 · Cited by 58
Chen, C., Okita, Y., Watanabe, Y., Abe, F., Fikry, M. A., Ichikawa, Y., Suzuki, H., Shibuya, A., & Kato, M. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0599 · Cited by 58
Haspels, H. N., Rahman, M. A., Joseph, J. V., Navarro, A. G., & Chekenya, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01345 · Cited by 57
Lee, H., Lee, H., Jung, J. H., Shin, E. A., & Kim, S. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12496 · Cited by 55
Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells
Robertis, M. D., Poeta, M. L., Signori, E., & Fazio, V. M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.008 · Cited by 54
Liu, Y., Geng, Y., Yang, H., Yang, H. K., Zhou, Y., Zhang, H., Tian, X., & Fang, W. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.043 · Cited by 52
Ji, C., Yang, L., Yi, W., Xiang, D., Wang, Y., Zhou, Z.-H., Qian, F., Ren, Y., Cui, W., Zhang, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0226-z · Cited by 47
Cai, M., Xu, X., Yan, S.-L., Sun, Z., Yin, Y., Wang, B., & Tu, Y. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0836-x · Cited by 46
Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth
Zhang, W., Zhao, J.-M., Lin, J., Hu, C.-Z., Zhang, J., YANG, W.-L., Zhang, J., Zhang, J., & Zhu, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.103 · Cited by 43
Rafael, D. F. D. S., Gener, P., Andrade, F., Seras‐Franzoso, J., Montero, S., Fernández, Y., Hidalgo, M. M., Arango, D., Sayós, J., Florindo, H. F., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461276 · Cited by 41
Yun, X., Zhang, K., Wang, J., Pangeni, R. P., Yang, L., Bonner, M., Wu, J., Wang, J., Nardi, I. K., Gao, M., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0042 · Cited by 39
Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1
Shah, D., Wyatt, D. L., Baker, A. T., Simms, P. E., Peiffer, D. S., Fernandez, M., Rakha, E. A., Green, A. R., Filipovic, A., Miele, L., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1952 · Cited by 39
Chen, Z., Li, W., Qiu, F., Huang, Q., Jiang, Z., Ye, J., Cheng, P., Low, C., Guo, Y., Yi, X., et al. (2018) · Theranostics · doi:10.7150/thno.24284 · Cited by 38
Mei, Y., Liu, Y., Cao, S., Tian, Z., & Zhou, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0972-4 · Cited by 38
Golan, H., Shukrun, R., Caspi, R., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.07.010 · Cited by 31
p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer
Sui, X. Y., Cai, J., Li, H., He, C., Zhou, C., Dong, Y., Chen, L., Zhang, B., Wang, Y., Zhang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0541-x · Cited by 30
Jaeckel, S., Kaller, M., Jackstadt, R., Götz, U., Müller, S., Boos, S. L., Horst, D. A., Jung, P., & Hermeking, H. (2018) · Nature Communications · doi:10.1038/s41467-018-06001-x · Cited by 25
Koifman, G., Shetzer, Y., Eizenberger, S., Solomon, H., Rotkopf, R., Molchadsky, A., Lonetto, G., Goldfinger, N., & Rotter, V. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0805 · Cited by 24
Liu, F., Wu, X., Jiang, X., Qian, Y., & Gao, J. X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0801-8 · Cited by 22
Shi, F., Li, M., Wang, J., Wu, D., Pan, M., Guo, M., & Dou, J. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0885-2 · Cited by 16
Cited by
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
Hu, J. L., Wang, W., Lan, X. L., Zeng, Z. C., Liang, Y. S., Yan, Y. R., Song, F. Y., Wang, F. F., Zhu, X. H., Liao, W. J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1019-x · Cited by 773
Comprehensive analysis of spatial architecture in primary liver cancer
Wu, R., Guo, W., Qiu, X., Wang, S., Sui, C., Lian, Q., Wu, J., Shan, Y., Yang, Z., Yang, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3750 · Cited by 369
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Pan, G., Liu, Y., Shang, L., Zhou, F., & Yang, S. (2021) · Cancer Communications · doi:10.1002/cac2.12138 · Cited by 362
Yuan, L., Xu, Z.-Y., Ruan, S.-M., Mo, S., Qin, J.-J., & Cheng, X.-D. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01219-0 · Cited by 329
Metadata
- Authors
- Najafi, M., Farhood, B., & Mortezaee, K.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-11-11
- Volume
- 234
- Issue
- 6
- Pages
- 8381-8395
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2901725551
- Cited by
- 573
- References
- 100
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.